Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This article compares withdrawal strategies using multi-asset portfolios versus the SP 500, highlighting risk, diversification, and potential retirement outcomes.
23,797 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
Investors are watching Meta Platforms for a potential stock split. This guide explains how splits work, what they mea...
Solana faces both headwinds and catalysts as 2026 unfolds. This guide breaks down when to consider solana buy, sell, ...
As traditional bonds struggle to keep pace with inflation, boomers are flocking to high-yield ETFs paying that 10% yi...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
Rising memory costs are pushing Apple to raise prices higher. This article examines how that could affect margins, de...
Private SpaceX uses extended lockups for insiders, signaling a disciplined cash strategy. This article breaks down wh...
A 25 percent drop often triggers fear and temptation to buy the dip. This article breaks down IBM s recent results, t...
Apple’s latest product lineup signals more than new gadgets—it signals a large-scale AI strategy. This article breaks...